Skip to content
2000
Volume 2, Issue 3
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Treatment of testicular germ cell tumors (TGCTs) has been a success primarily due to the exquisite responsiveness of this solid tumor to cisplatin-based therapy. Despite the promise of cure for the majority of TGCT patients, the effectiveness of therapy for some patients is limited by toxicity and the problem of resistance. There is compelling rationale to further understand the biology of TGCTs in order to better treat other solid tumors and to address the shortcomings of present TGCT therapies. TGCTs contain undifferentiated pluripotent stem cells, known as embryonal carcinoma, that share many properties with human embryonic stem cells. The importance of cancer stem cells in the initiation, progression and treatment of solid tumors is beginning to emerge. We discuss TGCTs in the context of solid tumor curability and targeted cancer stem cell therapy.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/157339406777934681
2006-08-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/157339406777934681
Loading

  • Article Type:
    Research Article
Keyword(s): 04-Oct; cancer stem cell; chemosensitivity; Cisplatin; embryonal carcinoma; Nanog; self-renewa
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test